Clinical Trial Update: Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM) [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating denagliptin in adults with type 2 diabetes mellitus (Phase 2/3) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Denagliptin (Denagliptin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Type 2 Diabetes Mellitus | Phase 2, Phase 3 | Status: WITHDRAWN